Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Von Willebrand Disease (VWD): later-stage trial registry
3 of 5 indexed Von Willebrand Disease (VWD) trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Von Willebrand Disease (VWD): 5 US clinical trials tracked, 3 recruiting.
Von Willebrand Disease (VWD) is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Hikari Dx, running 1 of these trials.
Enrollment posture brief
Registry condition von-willebrand-disease-vwd
OPEN 3 | RECR 60% | LATE 3 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
Von Willebrand Disease (VWD) lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Von Willebrand Disease (VWD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Von Willebrand Disease (VWD) is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Von Willebrand Disease (VWD) research.
Hikari Dx accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Von Willebrand Disease (VWD) trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Von Willebrand Disease (VWD) splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Hemab ApS
NCT06610201
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Vega Therapeutics
NCT07115004
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
NCT05582993
T-TAS® wS Method Comparison
Hikari Dx
NCT06710262
A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)
Baxalta now part of Shire
NCT03879135
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Von Willebrand Disease (VWD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Von Willebrand Disease (VWD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Von Willebrand Disease (VWD) page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Von Willebrand Disease (VWD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Hikari Dx sponsors the most Von Willebrand Disease (VWD) trials on record, review their full trial history before evaluating a specific study. See Hikari Dx's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Von Willebrand Disease (VWD) condition card totals 5 registered trials; most-linked intervention rFVIII; top US site state Indiana. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.